Publicaciones en colaboración con investigadores/as de University of Sydney (4)

2023

  1. Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial

    American Journal of Kidney Diseases, Vol. 82, Núm. 1, pp. 84-96.e1

2021

  1. Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE Trial

    Circulation, Vol. 143, Núm. 18, pp. 1735-1749

  2. Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: The CREDENCE trial

    European Heart Journal, Vol. 42, Núm. 48, pp. 4891-4901

2016

  1. International Multi-Specialty Delphi Survey: Identification of Diagnostic Criteria for Hepatic and Renal Cyst Infection

    Nephron, Vol. 134, Núm. 4, pp. 205-214